Imatinib buys time for brain after stroke

Nat Med. 2008 Jul;14(7):712-3. doi: 10.1038/nm0708-712.
No abstract available

Publication types

  • News
  • Comment

MeSH terms

  • Animals
  • Benzamides
  • Blood-Brain Barrier / pathology
  • Brain / blood supply
  • Brain / metabolism*
  • Brain / pathology*
  • Brain Ischemia / drug therapy
  • Cerebral Arteries / metabolism
  • Disease Models, Animal
  • Dose-Response Relationship, Drug
  • Humans
  • Imatinib Mesylate
  • Lymphokines / antagonists & inhibitors*
  • Mice
  • Models, Biological
  • Piperazines / therapeutic use*
  • Platelet-Derived Growth Factor / antagonists & inhibitors*
  • Pyrimidines / therapeutic use*
  • Radiography
  • Receptor, Platelet-Derived Growth Factor alpha / antagonists & inhibitors
  • Signal Transduction / drug effects
  • Stroke / diagnostic imaging
  • Stroke / drug therapy*
  • Time Factors

Substances

  • Benzamides
  • Lymphokines
  • Piperazines
  • Platelet-Derived Growth Factor
  • Pyrimidines
  • platelet-derived growth factor C
  • Imatinib Mesylate
  • Receptor, Platelet-Derived Growth Factor alpha